Table 1.
Baseline | 1-y Follow-Up | P Values | |
---|---|---|---|
Subjects, n | 44 | 44 | – |
Eye, n | 88 | 88 | – |
Age, y | 40.1 ± 10.3 | 41.2 ± 10.3 | NA |
Gender, F:M | 38:6 | 38:6 | – |
Follow-up duration (mo) | NA | 11.8 ± 2.2 | NA |
SBP (mm Hg) | 119.3 ± 11.8 | 122.4 ± 12.6 | 0.129 |
DBP (mm Hg) | 79.2 ± 8.9 | 79.4 ± 7.9 | 0.872 |
MAP (mm Hg) | 92.5 ± 9.1 | 93.7 ± 8.9 | 0.505 |
HR (beat per minute) | 72.5 ± 11.3 | 72.5 ± 10.8 | 0.774 |
IOP (mm Hg) | 15.5 ± 2.4 | 16.1 ± 2.3 | 0.285 |
MOPP (mm Hg) | 51.1 ± 6.1 | 51.7 ± 6.0 | 0.774 |
EDSS scores | 2.4 ± 1.7 | 2.5 ± 1.7 | 0.439 |
DD (y) | 5.7 ± 6.7 | 6.8 ± 6.7 | – |
F, female; M, male; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure = DBP + (1/3) (SBP-DBP); HR, heart rate; IOP, intraocular pressure; MOPP, mean ocular perfusion pressure = (2/3) (MAP-IOP); EDSS, Expanded Disability State Scale; DD, disease duration; -, not performed; NA, not applicable.